Cerevel drug for Parkinson’s disease improved symptom control in trial
Cerevel Therapeutics, which AbbVie is acquiring, said Thursday its drug tavapadon, taken with the common Parkinson’s drug levodopa, showed positive results in controlling motor symptoms.